Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

1.35
Delayed Data
As of 3:59pm ET
 -0.0904 / -6.28%
Today’s Change
1.28
Today|||52-Week Range
6.15
-22.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization9.0K8.0K8.0K7.0K
 
 
 
 
 
 
Operating ExpensesGross Income-9.0K-8.0K-8.0K-7.0K
 
 
 
 
 
General Expenses2.7M2.5M2.1M2.2M
 
 
 
 
 
Research And Development1.3M1.2M950.0K739.0K
 
 
 
 
 
Total Operating Expenses2.7M2.5M2.1M2.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-2.7M-2.5M-2.1M-2.2M
 
 
 
 
 
Other Expenses820.0K16.0K6.0K68.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.9M-2.5M-2.1M-2.1M
 
 
 
 
 
Income Taxes-306.0K-268.0K-219.0K-200.0K
 
 
 
 
 
Preferred Dividend-50.0K-50.0K-7.1M-214.0K
 
 
 
 
 
Net Income-1.6M-2.2M-1.9M-1.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS4.3M4.4M9.8M12.0M
 
 
 
 
 
Shares To Calculate EPS Diluted4.3M4.4M9.8M12.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.38-$0.50-$0.91-$0.17
 
 
 
 
 
EPS Diluted-$0.38-$0.50-$0.91-$0.17